Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Rugo

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
The breast cancer continuum in hormone-receptor-positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitorsH S Rugo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2014
Reply to the letter to the editor 'Everolimus, when combined with exemestane, adds toxicity with minimal benefit for women with breast cancer' Tannock and PondH S Rugo, M Aapro
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2018
Reply to the letter to the editor 'Reporting of HRQoL results from the PALOMA-2 trial: unfounded conclusions due to highly biased analyses' by Kaiser et alH S Rugo, S Iyer, C Huang
Breast Cancer Research and Treatment|January 11, 2022
Immunotherapy toxicity: identification and managementO Gumusay, J Callan, H S Rugo
American Journal of Ophthalmology|August 1, 1996
Bone marrow transplantation retinopathy in the absence of radiation therapyE T Cunningham, A R Irvine, H S Rugo
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 22, 2013
Informational needs of patients with metastatic breast cancer: what questions do they ask, and are physicians answering them?M Danesh, J Belkora, S Volz, et al.
Bone Marrow Transplantation|January 1, 1996
Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemiaL E Damon, H S Rugo, C A Ries, et al.
ESMO Open|August 14, 2022
Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancerH S Rugo, G Bianchini, J Cortes, et al.
Leukemia|April 1, 1994
Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemiaL E Damon, H S Rugo, C A Ries, et al.
Blood|January 15, 1993
Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimenC A Linker, C A Ries, L E Damon, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
The breast cancer continuum in hormone-receptor-positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitorsH S Rugo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2014
Reply to the letter to the editor 'Everolimus, when combined with exemestane, adds toxicity with minimal benefit for women with breast cancer' Tannock and PondH S Rugo, M Aapro
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2018
Reply to the letter to the editor 'Reporting of HRQoL results from the PALOMA-2 trial: unfounded conclusions due to highly biased analyses' by Kaiser et alH S Rugo, S Iyer, C Huang
Breast Cancer Research and Treatment|January 11, 2022
Immunotherapy toxicity: identification and managementO Gumusay, J Callan, H S Rugo
American Journal of Ophthalmology|August 1, 1996
Bone marrow transplantation retinopathy in the absence of radiation therapyE T Cunningham, A R Irvine, H S Rugo
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 22, 2013
Informational needs of patients with metastatic breast cancer: what questions do they ask, and are physicians answering them?M Danesh, J Belkora, S Volz, et al.
Bone Marrow Transplantation|January 1, 1996
Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemiaL E Damon, H S Rugo, C A Ries, et al.
ESMO Open|August 14, 2022
Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancerH S Rugo, G Bianchini, J Cortes, et al.
Leukemia|April 1, 1994
Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemiaL E Damon, H S Rugo, C A Ries, et al.
Blood|January 15, 1993
Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimenC A Linker, C A Ries, L E Damon, et al.
Pageof 8